US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 49.420
  • +2.630+5.62%
Close Nov 8 16:00 ET
  • 49.420
  • 0.0000.00%
Post 20:01 ET
1.88BMarket Cap-11080P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.55%-14.4M
-72.00%-37.79M
-139.63%-117.49M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
-1,408.16%-49.03M
10.29%-10.87M
-361.68%-18.61M
Net income from continuing operations
-5.94%-33.29M
-52.57%-35.73M
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.43%-13.6M
-43.41%-22.51M
Operating gains losses
16,786.67%2.53M
509.09%201K
-123.31%-117K
-794.12%-152K
-172.22%-13K
-94.12%15K
-86.59%33K
-52.42%502K
92.70%-17K
-94.86%18K
Depreciation and amortization
31.32%239K
159.62%270K
169.85%877K
254.08%347K
159.57%244K
97.83%182K
153.66%104K
4.17%325K
145.00%98K
13.25%94K
Other non cash items
16.81%264K
6.03%246K
19.79%926K
21.61%242K
7.11%226K
15.90%226K
38.10%232K
-86.65%773K
71.55%199K
131.87%211K
Change In working capital
229.12%10.25M
-510.45%-8.59M
132.18%306K
-3,402.35%-2.81M
3,093.18%1.41M
214.90%3.12M
-186.27%-1.41M
-169.31%-951K
129.73%85K
-99.78%44K
-Change in receivables
-80.49%521K
-2,152.18%-13.65M
-304.90%-14.13M
-2,744.06%-11.34M
-80.54%-6.12M
1,037.19%2.67M
374.79%665K
-4,680.82%-3.49M
832.61%429K
-116.94%-3.39M
-Change in inventory
---692K
---929K
---3.11M
---3.09M
---15K
--0
--0
--0
--0
----
-Change in prepaid assets
255.89%767K
314.40%1.07M
-300.69%-2.89M
-46.31%-1.86M
-198.51%-793K
58.31%-492K
-72.25%257K
64.71%-721K
7.83%-1.27M
-6.83%805K
-Change in payables and accrued expense
507.95%9.17M
313.99%5.05M
491.93%20.97M
1,163.90%13.41M
219.13%8.41M
233.66%1.51M
-341.70%-2.36M
-37.18%3.54M
16.72%1.06M
915.48%2.63M
-Change in other current assets
188.79%483K
178.95%106K
-233.95%-718K
21.43%-110K
---102K
-511.24%-544K
171.43%38K
90.51%-215K
-128.17%-140K
--0
-Change in other current liabilities
96.55%-1K
-2,800.00%-232K
376.12%185K
2,600.00%189K
1,200.00%33K
-3.57%-29K
81.40%-8K
-158.26%-67K
120.00%7K
-106.98%-3K
Cash from discontinued investing activities
Operating cash flow
39.55%-14.4M
-72.00%-37.79M
-139.63%-117.49M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
-1,408.16%-49.03M
10.29%-10.87M
-361.68%-18.61M
Investing cash flow
Cash flow from continuing investing activities
-163.23%-40.53M
-1,005.12%-102.22M
197.22%140.6M
120.47%17.85M
182.92%47.37M
52,634.43%64.09M
7,114.91%11.29M
-24,580.72%-144.63M
-31,731.75%-87.22M
-47,112.40%-57.13M
Net PPE purchase and sale
-32.02%-1.04M
48.82%-174K
-196.84%-1.5M
--0
-290.63%-375K
-545.08%-787K
-111.18%-340K
13.65%-506K
53.65%-127K
20.66%-96K
Net intangibles purchase and sale
----
----
---4M
--0
----
----
----
--0
--0
----
Net investment purchase and sale
-160.86%-39.49M
-977.17%-102.05M
201.38%146.11M
120.50%17.85M
190.73%51.74M
--64.88M
--11.63M
---144.12M
---87.09M
---57.03M
Cash from discontinued investing activities
Investing cash flow
-163.23%-40.53M
-1,005.12%-102.22M
197.22%140.6M
120.47%17.85M
182.92%47.37M
52,634.43%64.09M
7,114.91%11.29M
-24,580.72%-144.63M
-31,731.75%-87.22M
-47,112.40%-57.13M
Financing cash flow
Cash flow from continuing financing activities
8,197.84%42.32M
2,069.78%108.77M
38.50%130.18M
7,384.85%19.76M
77,227.21%104.89M
-99.32%510K
-73.79%5.01M
447,457.14%93.99M
456.76%264K
-281.33%-136K
Net issuance payments of debt
--75M
--0
-50.00%10M
--0
--5M
--0
-75.00%5M
--20M
--0
--0
Net common stock issuance
---9.64M
--107.97M
59.51%118.6M
--19.22M
45,685.78%99.38M
--0
--0
--74.35M
--0
---218K
Proceeds from stock option exercised by employees
479.22%2.95M
6,069.23%802K
169.57%1.58M
103.79%538K
529.27%516K
113.39%510K
--13K
80.56%585K
15.28%264K
9.33%82K
Net other financing activities
----
----
----
----
----
----
----
-213.53%-950K
--0
--0
Cash from discontinued financing activities
Financing cash flow
8,197.84%42.32M
2,069.78%108.77M
38.50%130.18M
7,384.85%19.76M
77,227.21%104.89M
-99.32%510K
-73.79%5.01M
447,457.14%93.99M
456.76%264K
-281.33%-136K
Net cash flow
Beginning cash position
193.51%193.71M
213.91%224.95M
-58.17%71.66M
33.74%226.67M
-56.48%106.77M
-62.29%66M
-58.17%71.66M
1.89%171.33M
-7.79%169.49M
38.83%245.36M
Current changes in cash
-130.93%-12.61M
-451.69%-31.24M
253.79%153.29M
98.24%-1.73M
258.02%119.9M
-42.04%40.78M
-253.97%-5.66M
-3,231.39%-99.67M
-684.58%-97.83M
-1,173.79%-75.87M
End cash Position
69.61%181.1M
193.51%193.71M
213.91%224.95M
213.91%224.95M
33.74%226.67M
-56.48%106.77M
-62.29%66M
-58.17%71.66M
-58.17%71.66M
-7.79%169.49M
Free cash flow
37.26%-15.44M
-70.16%-37.96M
-148.29%-123M
-257.56%-39.34M
-96.38%-36.74M
-461.81%-24.61M
-44.43%-22.31M
-1,666.60%-49.54M
11.25%-11M
-367.59%-18.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.55%-14.4M-72.00%-37.79M-139.63%-117.49M-261.73%-39.34M-73.89%-32.36M-459.43%-23.83M-43.73%-21.97M-1,408.16%-49.03M10.29%-10.87M-361.68%-18.61M
Net income from continuing operations -5.94%-33.29M-52.57%-35.73M-118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.43%-13.6M-43.41%-22.51M
Operating gains losses 16,786.67%2.53M509.09%201K-123.31%-117K-794.12%-152K-172.22%-13K-94.12%15K-86.59%33K-52.42%502K92.70%-17K-94.86%18K
Depreciation and amortization 31.32%239K159.62%270K169.85%877K254.08%347K159.57%244K97.83%182K153.66%104K4.17%325K145.00%98K13.25%94K
Other non cash items 16.81%264K6.03%246K19.79%926K21.61%242K7.11%226K15.90%226K38.10%232K-86.65%773K71.55%199K131.87%211K
Change In working capital 229.12%10.25M-510.45%-8.59M132.18%306K-3,402.35%-2.81M3,093.18%1.41M214.90%3.12M-186.27%-1.41M-169.31%-951K129.73%85K-99.78%44K
-Change in receivables -80.49%521K-2,152.18%-13.65M-304.90%-14.13M-2,744.06%-11.34M-80.54%-6.12M1,037.19%2.67M374.79%665K-4,680.82%-3.49M832.61%429K-116.94%-3.39M
-Change in inventory ---692K---929K---3.11M---3.09M---15K--0--0--0--0----
-Change in prepaid assets 255.89%767K314.40%1.07M-300.69%-2.89M-46.31%-1.86M-198.51%-793K58.31%-492K-72.25%257K64.71%-721K7.83%-1.27M-6.83%805K
-Change in payables and accrued expense 507.95%9.17M313.99%5.05M491.93%20.97M1,163.90%13.41M219.13%8.41M233.66%1.51M-341.70%-2.36M-37.18%3.54M16.72%1.06M915.48%2.63M
-Change in other current assets 188.79%483K178.95%106K-233.95%-718K21.43%-110K---102K-511.24%-544K171.43%38K90.51%-215K-128.17%-140K--0
-Change in other current liabilities 96.55%-1K-2,800.00%-232K376.12%185K2,600.00%189K1,200.00%33K-3.57%-29K81.40%-8K-158.26%-67K120.00%7K-106.98%-3K
Cash from discontinued investing activities
Operating cash flow 39.55%-14.4M-72.00%-37.79M-139.63%-117.49M-261.73%-39.34M-73.89%-32.36M-459.43%-23.83M-43.73%-21.97M-1,408.16%-49.03M10.29%-10.87M-361.68%-18.61M
Investing cash flow
Cash flow from continuing investing activities -163.23%-40.53M-1,005.12%-102.22M197.22%140.6M120.47%17.85M182.92%47.37M52,634.43%64.09M7,114.91%11.29M-24,580.72%-144.63M-31,731.75%-87.22M-47,112.40%-57.13M
Net PPE purchase and sale -32.02%-1.04M48.82%-174K-196.84%-1.5M--0-290.63%-375K-545.08%-787K-111.18%-340K13.65%-506K53.65%-127K20.66%-96K
Net intangibles purchase and sale -----------4M--0--------------0--0----
Net investment purchase and sale -160.86%-39.49M-977.17%-102.05M201.38%146.11M120.50%17.85M190.73%51.74M--64.88M--11.63M---144.12M---87.09M---57.03M
Cash from discontinued investing activities
Investing cash flow -163.23%-40.53M-1,005.12%-102.22M197.22%140.6M120.47%17.85M182.92%47.37M52,634.43%64.09M7,114.91%11.29M-24,580.72%-144.63M-31,731.75%-87.22M-47,112.40%-57.13M
Financing cash flow
Cash flow from continuing financing activities 8,197.84%42.32M2,069.78%108.77M38.50%130.18M7,384.85%19.76M77,227.21%104.89M-99.32%510K-73.79%5.01M447,457.14%93.99M456.76%264K-281.33%-136K
Net issuance payments of debt --75M--0-50.00%10M--0--5M--0-75.00%5M--20M--0--0
Net common stock issuance ---9.64M--107.97M59.51%118.6M--19.22M45,685.78%99.38M--0--0--74.35M--0---218K
Proceeds from stock option exercised by employees 479.22%2.95M6,069.23%802K169.57%1.58M103.79%538K529.27%516K113.39%510K--13K80.56%585K15.28%264K9.33%82K
Net other financing activities -----------------------------213.53%-950K--0--0
Cash from discontinued financing activities
Financing cash flow 8,197.84%42.32M2,069.78%108.77M38.50%130.18M7,384.85%19.76M77,227.21%104.89M-99.32%510K-73.79%5.01M447,457.14%93.99M456.76%264K-281.33%-136K
Net cash flow
Beginning cash position 193.51%193.71M213.91%224.95M-58.17%71.66M33.74%226.67M-56.48%106.77M-62.29%66M-58.17%71.66M1.89%171.33M-7.79%169.49M38.83%245.36M
Current changes in cash -130.93%-12.61M-451.69%-31.24M253.79%153.29M98.24%-1.73M258.02%119.9M-42.04%40.78M-253.97%-5.66M-3,231.39%-99.67M-684.58%-97.83M-1,173.79%-75.87M
End cash Position 69.61%181.1M193.51%193.71M213.91%224.95M213.91%224.95M33.74%226.67M-56.48%106.77M-62.29%66M-58.17%71.66M-58.17%71.66M-7.79%169.49M
Free cash flow 37.26%-15.44M-70.16%-37.96M-148.29%-123M-257.56%-39.34M-96.38%-36.74M-461.81%-24.61M-44.43%-22.31M-1,666.60%-49.54M11.25%-11M-367.59%-18.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data